Invention Grant
US09266852B2 Daidzein derivative, pharmaceutically acceptable salt and preparation method thereof, and pharmaceutical composition containing same
有权
黄豆苷衍生物，药学上可接受的盐及其制备方法以及含有它们的药物组合物
- Patent Title: Daidzein derivative, pharmaceutically acceptable salt and preparation method thereof, and pharmaceutical composition containing same
- Patent Title (中): 黄豆苷衍生物，药学上可接受的盐及其制备方法以及含有它们的药物组合物
-
Application No.: US14362890Application Date: 2012-11-28
-
Publication No.: US09266852B2Publication Date: 2016-02-23
- Inventor: Jun Bai , Caiyue Shen , Shigao Hu
- Applicant: ANHUI BIOCHEM BIO-PHARMACEUTICAL CO., LTD
- Applicant Address: CN Anhui
- Assignee: Anhui Biochem Bio-Pharmaceutical Co., Ltd
- Current Assignee: Anhui Biochem Bio-Pharmaceutical Co., Ltd
- Current Assignee Address: CN Anhui
- Agency: Lewis Roca Rothgerber Christie LLP
- Priority: CN201110401307 20111206
- International Application: PCT/CN2012/085452 WO 20121128
- International Announcement: WO2013/083014 WO 20130613
- Main IPC: C07D311/00
- IPC: C07D311/00 ; C07D311/36 ; A61K31/352 ; A61K9/19
Abstract:
Disclosed is a daidzein derivative as represented by formula (I), or pharmaceutically acceptable salt thereof. Compared to the daidzein in the prior art, the daidzein derivative hydrochloride, in particular to the 7-O—N,N-diethyl-aminoacetyl daidzein hydrochloride, prepared by the daidzein derivative of the present invention, has better solubility and effect for treating cardiovascular diseases.
Public/Granted literature
Information query
